anemia: implications for the anemia of chronic disease Inappropriate expression of hepcidin is associated with iron refractory

[1]  C. Beaumont,et al.  Severe iron deficiency anemia in transgenic mice expressing liver hepcidin , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[2]  J. Burns,et al.  Bass hepcidin is a novel antimicrobial peptide induced by bacterial challenge. , 2002, European journal of biochemistry.

[3]  W. Sly,et al.  Hepcidin: A putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[4]  C. Beaumont,et al.  Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Christina H. Park,et al.  Hepcidin, a Urinary Antimicrobial Peptide Synthesized in the Liver* , 2001, The Journal of Biological Chemistry.

[6]  Bruno Turlin,et al.  A New Mouse Liver-specific Gene, Encoding a Protein Homologous to Human Antimicrobial Peptide Hepcidin, Is Overexpressed during Iron Overload* , 2001, The Journal of Biological Chemistry.

[7]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[8]  N. Andrews,et al.  Iron homeostasis: insights from genetics and animal models , 2000, Nature Reviews Genetics.

[9]  Peter Schulz-Knappe,et al.  LEAP‐1, a novel highly disulfide‐bonded human peptide, exhibits antimicrobial activity , 2000, FEBS letters.

[10]  N. Andrews,et al.  The molecular defect in hypotransferrinemic mice. , 2000, Blood.

[11]  R. Means.  The anaemia of infection. , 2000, Bailliere's best practice & research. Clinical haematology.

[12]  R. Means,et al.  Advances in the anemia of chronic disease. , 1999, International journal of hematology.

[13]  G. Weiss,et al.  Iron and anemia of chronic disease. , 1999, Kidney international. Supplement.

[14]  Gregory J. Anderson,et al.  Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse , 1999, Nature Genetics.

[15]  R. Jurado.  Iron, infections, and anemia of inflammation. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  N. Andrews,et al.  Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene , 1997, Nature genetics.

[17]  M. Loda,et al.  CDC25 phosphatases as potential human oncogenes. , 1995, Science.

[18]  C. Alter,et al.  Glycogen Storage Disease in Adults , 1994, Annals of Internal Medicine.

[19]  L. Moldawer,et al.  Cachectin/tumor necrosis factor‐α alters red blood cell kinetics and induces anemia in vivo , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  Lee Gr.  The anemia of chronic disease. , 1983, Seminars in hematology.

[21]  S. Cortell,et al.  Effect of endotoxin on iron absorption. , 1967, The American journal of physiology.

[22]  Mingyi Chen,et al.  Glycogen Storage Diseases , 2011 .

[23]  D. A. Weinstein,et al.  Effect of continuous glucose therapy with uncooked cornstarch on the long-term clinical course of type 1a glycogen storage disease , 2002, European Journal of Pediatrics.

[24]  R. Means.  Pathogenesis of the anemia of chronic disease: A cytokine‐mediated anemia , 1995, Stem cells.

[25]  E. Weinberg.  Iron depletion: a defense against intracellular infection and neoplasia. , 1992, Life sciences.

[26]  J. Torrance.  Tissue iron stores , 1980 .